UPDATE: Genomic Solutions to Slash 25% of Jobs; Future of Proteomics Effort Uncertain | GenomeWeb

NEW YORK, Sept. 7 – Proteomics and microarray developer Genomic Solutions said on Friday it plans to cut 25 percent of its workforce and restructure its business to help it become profitable by the first quarter of next year. 

The company said in a statement that the restructuring includes the closing of an R&D and manufacturing facility in Lansing, Michigan. Jobs associated with that space will be transplanted to the company’s headquarters in Ann Arbor. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."